Genentech reviews

Key Performance Initiatives and metrics are unrealistic and can be a guarantee of failure. Some managers are not equipped to manage people.

Roche acquisition has damaged the company to a point of no return. Management is poor. Compensation not competative. Hard to get promoted. Senior employees and scientists are leaving the company. Roche stifles creativity and independent thinking. Mistakes are not considered opportunities to grow and learn. Empolyees not promoted from within. Mangers often do not know the job/work which leads to wrong decision making. There is a new environment of hierarchy, ie decisions are top down, there is a new attitude that degrees mean more than on the job experience.